Form 8-K - Current report:
SEC Accession No. 0001628280-25-010535
Filing Date
2025-03-05
Accepted
2025-03-05 16:58:58
Documents
13
Period of Report
2025-02-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20250227.htm   iXBRL 8-K 26964
  Complete submission text file 0001628280-25-010535.txt   149391

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20250227.xsd EX-101.SCH 1788
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20250227_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20250227_pre.xml EX-101.PRE 12512
15 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20250227_htm.xml XML 2706
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 25712166
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)